Simon P. Chandler

Simon P. Chandler is an experienced pharmaceutical executive currently serving as VP and Head of Ophthalmology at Chromocell Therapeutics.1 He is based in Warwick, Rhode Island, United States.1

Career History

Simon has an extensive background in ophthalmology and clinical research:

Current Role:

• VP and Head of Ophthalmology at Chromocell Therapeutics1

Previous Positions:

• Executive Director of Clinical Development at Nevakar Inc. (July 2020 - Present)1
• Principal at Sci-pHecta Ltd. Consulting (October 2013 - July 2020)1
• Senior Director of Strategic and Business Development at Ora, Inc. (March 2016 - October 2018)1
• Senior Director of Clinical Ophthalmology at Oxford BioMedica (July 2014 - September 2015)1
• Vice President of Clinical Research at NightStaRx BioPharmaceuticals (January 2014 - September 2014)1

Expertise

Simon specializes in:

• Clinical development and regulatory interaction
• Ophthalmic development, including small molecule, biologic, and gene therapies
• Study development for various eye conditions, including retinal diseases, glaucoma, dry eye, and cataract-IOL implantation1

He has particular expertise in driving EU company development in the US and has worked extensively with cutting-edge gene therapies.1

Education

• Ph.D. in Molecular Biology (Epigenetics and Tertiary structure-related gene regulation) from the University of Southampton (1997-2001)1
• B.Sc. in Molecular Biology from the University of Portsmouth (1994-1997)1

Simon P. Chandler's diverse experience in ophthalmology, clinical research, and gene therapy positions him as a leader in the field of ophthalmic therapeutics development.